Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Kinetics and Protection Duration-Reference-Cited by-同舟云学术

Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Kinetics and Protection Duration

Published:2021-11-27 Issue: Volume: Page:
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Dimeglio Chloé¹²,Herin Fabrice³⁴,Da-Silva Isabelle¹,Porcheron Marion¹,Martin-Blondel Guillaume²⁵,Chapuy-Regaud Sabine¹,Izopet Jacques¹²

Affiliation:

1. HU Toulouse, Hôpital Purpan, Virology Laboratory, Toulouse, France

2. INSERM UMR1291–CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), Toulouse, France

3. Occupational Diseases Department, Toulouse University Hospital, Toulouse, France

4. UMR1295, Unité Mixte INSERM–Université Toulouse III Paul Sabatier, Centre for Epidemiology and Research in Population Health Unit (CERPOP), Toulouse, Franceand

5. Infectious and Tropical Diseases Department, Toulouse University Hospital, Toulouse, France

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciab984/42127616/ciab984.pdf

Reference5 articles.

1. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months.;Levin;N Engl J Med,2021

2. Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19.;Doria-Rose;N Engl J Med,2021

3. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.;Tartof;Lancet,2021

4. Kinetics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody avidity maturation and association with disease severity.;Luo;Clin Infect Dis,2021

5. Antibody titers and protection against a SARS-CoV-2 infection.;Dimeglio;J Infect,2021

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjects;International Journal of Infectious Diseases;2024-01

2. Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection;Nature Communications;2023-05-26

3. COVID-19 mRNA vaccine immunogenicity decay and breakthrough illness in adolescents and young adults with childhood-onset rheumatic diseases;Rheumatology;2023-01-20

4. The persistence of SARS-CoV-2 neutralizing antibodies after COVID-19: A one-year observation. Is a SARS-CoV-2 vaccination booster dose necessary?;Central European Journal of Immunology;2023

5. Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection;2022-12-13